Advanced company searchLink opens in new window

ACORUS THERAPEUTICS LIMITED

Company number 03976183

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
28 Apr 2020 CS01 Confirmation statement made on 16 April 2020 with updates
28 Apr 2020 PSC07 Cessation of Sinclair Pharma Plc as a person with significant control on 28 April 2020
07 Oct 2019 AP03 Appointment of Mrs Lucy Jane Benson as a secretary on 1 October 2019
07 Oct 2019 TM02 Termination of appointment of Jason Rodney Tate as a secretary on 31 July 2019
24 Jul 2019 AA Audit exemption subsidiary accounts made up to 31 December 2018
24 Jul 2019 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/18
24 Jul 2019 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/18
24 Jul 2019 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/18
24 Apr 2019 CS01 Confirmation statement made on 16 April 2019 with no updates
20 Sep 2018 AA Audit exemption subsidiary accounts made up to 31 December 2017
20 Sep 2018 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/17
20 Sep 2018 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/17
20 Sep 2018 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/17
24 Apr 2018 CS01 Confirmation statement made on 16 April 2018 with no updates
16 Apr 2018 AD01 Registered office address changed from Office Village Chester Business Park Chester Cheshire CH4 9QZ to Eden House Lakeside Chester Business Park Chester CH4 9QT on 16 April 2018
04 Apr 2018 MR04 Satisfaction of charge 039761830005 in full
11 Oct 2017 AA Audit exemption subsidiary accounts made up to 31 December 2016
11 Oct 2017 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/16
11 Oct 2017 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/16
11 Oct 2017 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/16
20 Jul 2017 PSC07 Cessation of Sinclair Pharma Management Ltd as a person with significant control on 20 July 2017
20 Jul 2017 PSC07 Cessation of Sinclair Pharma Holdings Limited as a person with significant control on 20 July 2017
24 Apr 2017 CS01 Confirmation statement made on 19 April 2017 with updates
20 Oct 2016 TM01 Termination of appointment of Christophe Herve Frederic Foucher as a director on 1 September 2016
29 Jul 2016 AA01 Current accounting period extended from 30 June 2016 to 31 December 2016